Linnartz
Johan P.m.g. Linnartz, Eindhoven NL
Patent application number | Description | Published |
---|---|---|
20100254712 | METHOD, SYSTEM AND DEVICE FOR TRANSMITTING LIGHTING DEVICE DATA - It is presented a method for transmitting lighting device data. The method comprises the steps of obtaining, in a lighting device, a subset of lighting device data, the lighting device data containg information of the lighting device, transmitting, from the lighting device, using light, the subset of lighting device data, and repeating the above steps until all subsets jointly corresponding to the complete lighting device data have been transmitted. A corresponding lighting device and lighting system are also presented. | 10-07-2010 |
20120105266 | METHOD AND DEVICE FOR DRIVING A LAMP - A method for driving a lamp ( | 05-03-2012 |
John-Paul Marie Gerard Linnartz, Eindhoven NL
Patent application number | Description | Published |
---|---|---|
20130315220 | METHOD FOR COMMUNICATING IN A NETWORK, A SYSTEM AND A PRIMARY STATION THEREFOR - The present invention relates to a system comprising at least one primary station and at least one secondary station, wherein the primary station comprises communication means for communicating with the secondary station in accordance with a first protocol, wherein the communication means are arranged for communicating with a plurality of further stations in accordance with a further protocol, and wherein the primary station comprises control means for generating a message to be broadcast to the secondary station, said message comprising purposely erroneous information causing the at least one secondary station to remain silent for a predetermined duration. | 11-28-2013 |
Ronald R. Linnartz, Andover, NJ US
Patent application number | Description | Published |
---|---|---|
20100173934 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER - The invention relates to a combination comprising a microtubule active agent; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination. | 07-08-2010 |
Ronald Richard Linnartz, Andover, NJ US
Patent application number | Description | Published |
---|---|---|
20090098137 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER - A combination of an mTOR inhibitor compound with one or more pharmaceutically active agents, for simultaneous, concurrent, separate or sequential use for preventing or treating a proliferative disease. | 04-16-2009 |
20090099103 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER - The invention relates to a combination comprising an Erb-B and VEGF receptor inhibitor; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination. | 04-16-2009 |
20110190312 | Combinations Comprising Epothilones and Protein Tyrosine Kinase Inhibitors and Pharmaceutical Uses Thereof - The invention relates to a combination which comprises: | 08-04-2011 |
20110257206 | Combinations of Therapeutic Agents for Treating Cancer - The invention relates to a combination comprising a microtubule active agent; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination. | 10-20-2011 |
20120129881 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER - A combination of an mTOR inhibitor compound with one or more pharmaceutically active agents, for simultaneous, concurrent, separate or sequential use for preventing or treating a proliferative disease. | 05-24-2012 |
20120252811 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER - The invention relates to a combination comprising a Bcr-Abl, c-Kit and PDGF-R tyrosine kinase inhibitor; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination. | 10-04-2012 |